Eupraxia Pharmaceuticals’ First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week

mental-health

Eupraxia Pharmaceuticals’ First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week

ONLY AVAILABLE IN PAID PLANS.

Originally reported by globenewswire. Read more

Source: https://www.globenewswire.com/news-release/2026/05/06/3288658/0/en/Eupraxia-Pharmaceuticals-First-Release-of-EoEHSS-Sub-Scores-Data-from-its-Ongoing-Phase-1b-2a-RESOLVE-Trial-in-Eosinophilic-Esophagitis-at-Digestive-Disease-Week.html